Source: Romanian Journal of Infectious Diseases.
Author s : Nicolae, Ilinca; Ene, Corina-Daniela; Georgescu, Simona Roxana Abstract: Molecular pathology of benign prostatic papilloma tumore gola is multifactorial and involves endocrine, biochemical, immunological interactions. The mechanisms involved in the onset and progression of benign prostatic hyperplasia are: infections, 50 years of age, hormones and neurotransmitters imbalances, inflammation, oxidative stress.
The potential role of glycosylation in the pathogenesis of prostate disease has been neglected.
In this study we documented the profile of gangliosides in normal and pathological prostatic tissues together with the pathologic changes seen in the level of extracellular gangliosides in patients with prostate pathology. Analysis of the data in the literature suggests that gangliosides may represent immunologic markers useful in the differential diagnosis between prostate cancer and benign prostatic hyperplasia.
- Ductal papilloma hyperplasia
- Pin on Articole interesante
- Curatare ficat si fiere
- Vierme circulare
- Hpv warts discharge
- Hpv cream aldara
- Dacă se transmit verucile genitale
English Copyright of Romanian Journal of Infectious Diseases is the property of Amaltea Medical Publishing Prostate cancer benign prostatic hyperplasia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.
However, users may print, download, or email articles for individual use. This abstract may be abridged.
No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use.
However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution.